Pipobroman

Pipobroman
Clinical data
Trade namesVercite, Vercyte
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H16Br2N2O2
Molar mass356.058 g·mol−1
3D model (JSmol)
  • O=C(N1CCN(C(=O)CCBr)CC1)CCBr
  • InChI=1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2 checkY
  • Key:NJBFOOCLYDNZJN-UHFFFAOYSA-N checkY
  (verify)

Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent,[1] and is marketed in France and Italy.[2]

References

  1. ^ Passamonti F, Lazzarino M (September 2003). "Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman". Leukemia & Lymphoma. 44 (9): 1483–8. doi:10.3109/10428190309178768. PMID 14565648.
  2. ^ "Pipobroman". Drugs.com.
Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.